Join
Live feed
·
PRReleasevia Quantisnow
Unity Biotechnology Inc. logo

UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema

ByQuantisnow·Wall Street's wire, on your screen.
UBX· Unity Biotechnology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UBX (Unity Biotechnology Inc.) and more on Quantisnow.